Biotech Rebound

Finally… An UP day for the biotech sector! The recent decline in the biotech stocks was just plain panic selling. A lot of the biotech stocks were simply in a free fall. Today’s M&A action with AstraZeneca (Ticker: AZN) buying out Cambridge Antibody Technology (Ticker: CATG) helped the group out a bit. And even insiders are starting to nibble at their company stock. Here’s a recent insider buy at Genzyme, click: here. Hmm… Maybe it's time to start buying.